ARTICLE | Clinical News
Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System regulatory update
November 5, 2012 8:00 AM UTC
Boston Scientific said it received CE Mark approval for its Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System for coronary artery lesions. The product is an everolimus-eluting stent w...